+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Expired

The Andrew McDonough B+ Foundation Childhood Cancer Research Grant Process

McDonough (Andrew) B+ (Be Positive) Foundation

The Andrew McDonough B+ (Be Positive) Foundation (www.BePositive.org) is the largest provider of financial assistance to families of kids with cancer nationwide.

Additionally, The B+ Foundation, with the help of a highly respected Scientific Advisory Board, funds cutting-edge childhood cancer research. The B+ Foundation funds grants that support basic, translational or clinical research, which may lead towards cures and better treatments for childhood cancers.

The 2025 Research Grant Cycle is open on ProposalCentral from June 1 - September 3, 2025.

Five to ten grants will be awarded. Each grant will be a 2 year grant of $75,000/yr for a total grant award of $150,000.

AI Based Application Success Predictor

The B+ Foundation: A Catalyst for Childhood Cancer Research & Support

The Andrew McDonough B+ Foundation was established in memory of 14-year-old Andrew McDonough, who faced leukemia with extraordinary resilience and inspired a “Be Positive” outlook during his battle. Its mission centers on four pillars:

Providing financial assistance to families affected by childhood cancer (it is the largest U.S. nonprofit in this space).

Funding cutting-edge childhood cancer research.

Increasing public awareness and advocacy to raise dedicated research funding.

Offering psychosocial support to children and their families.

B+ Foundation as a Predictor of Research Success

1. Focused Early-Stage Research Investment

The foundation has awarded over 250 research grants globally to date.

Grants support innovative, hypothesis-driven projects at leading institutions—such as St. Jude’s, Dana-Farber, Seattle Children’s, and Children’s Oncology Group.

These awards foster emerging scientists by enabling them to collect crucial preliminary data and launch high-impact studies in pediatric oncology.

2. Notable Funded Projects with Lifesaving Potential

Example: Dr. Max M. van Noesel at the Princess Máxima Center is developing a PET imaging agent to visualize GD2—a promising biomarker for neuroblastoma—in children.

Example: Dr. Jiao Zhang at Baylor College is investigating androgen-driven mechanisms behind deadly PFA ependymoma in infants, aiming to uncover new therapeutic strategies.

Such projects underscore the foundation’s role in accelerating translational research in childhood cancers.

3. Innovative Collaborations & Advocacy

The Foundation is a leading supporter of ACCELERATE, a European initiative drawing together industry, regulators, academia, and advocates to streamline pediatric cancer drug development.

By backing such partnerships, the Foundation ensures that early research has real-world impact and access to treatment pathways.

4. Track Record & Visibility

In recent years, the B+ Foundation has awarded nearly $1 million annually toward research and family support programs.

Its active engagement in both scientific and community spheres—from public events to academic collaborations—adds prestige and reach to its funding programs.

Summary Table: Why B+ Foundation Support Signals Success

Characteristic	Impact on Research & Careers
Targeted seed funding	Enables early-stage researchers to build high-impact, grant-ready projects
Cutting-edge project support	Propels novel investigations like neuroblastoma imaging and PFA ependymoma therapies
Collaborative ecosystems	Integration into global platforms like ACCELERATE enhances translational potential
National presence & credibility	Active in both advocacy and research spheres—it amplifies visibility and networks

Final Thoughts

While the B+ Foundation’s primary mission is centered on family support and positivity, its role in funding innovative childhood cancer research is a significant predictor of success for emerging scientists. Their grants empower researchers to produce meaningful discoveries, build visibility, and form indispensable networks—accelerating the path toward breakthroughs in pediatric oncology.

Specialties

Cancer

Pediatrics

Oncology

Eligibility Requirements

• Applicants must have a M.D., D.O., Ph.D, or PharmD degree

• Applicants may be Assistant, Associate or Professor level investigators

• Applications will be considered from instructors who have a minimum of a two-year commitment from an accredited academic institution

Sponsor Details

Sponsor Institute/Organizations: McDonough (Andrew) B+ (Be Positive) Foundation

Sponsor Type: Corporate/Non-Profit

Address: 101 Rockland Circle Wilmington, DE 19803

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity